Fecal pancreatic Elastase
The fecal pancreatic Elastase ELISA from BIOSERV Diagnostics has been registered with the FDA
For the diagnosis of a pancreatic insufficiency
In-vitro test kit for the quantitative detection of human fecal pancreatic elastase in stool in order to diagnose and quantify pancreatic insufficiency.
Advantages of determining fecal pancreatic elastase:
-
Fecal pancreatic Elastase is exclusively produced in the pancreas and therefore excellently suitable to diagnose pancreatic malfunctions like pancreatic insufficiency
-
Fecal pancreatic Elastase is extraordinary stable when passing through the bowels
-
Pancreatic Elastase is enriched 5-6 fold in feces in comparison to the concentration in the duodenal juice
-
Fecal pancreatic Elastase has a small intra-personal variation in regarding the concentration
-
Direct correlation of fecal pancreatic Elastase concentration and pancreatic function
-
no age-dependency of the fecal pancreatic elastase secretion from infancy (first year) on
-
the fecal pancreatic elastase molecule is stable for at least 6 days at refrigeration and for at least 3 days at room temperature
-
FDA-registered
The Bioserv Elastase ELISA for the detection of fecal pancreatic Elastase allows a highly sensitive and specific determination of fecal pancreatic Elastase, enabling the clinician to establish a prompt and reliable diagnosis of suspected cases of pancreatic insufficiency.
For more detailed information please click here: fecal pancreatic elastase detailed
For further information please send us an e-mail: info@bioserv-diagnostics.com